81525-10-2 Sell high quality Nafamostat produced in China factory Nafamostat seller in China
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
pecifications for NAFAMOSTAT MESYLATE CAS:81525-10-2
Product Name | NAFAMOSTAT MESYLATE |
Synonyms |
4-Guanidinobenzoic acid 6-amidino-2-naphtyl ester; 6-Amidino-2-naphthyl 4-guanidinobenzoate; Nafamostat Dimethanesulfonate; 6-carbamimidoylnaphthalen2-yl 4-(diaminomethyleneamino) benzoate;
NafamostatMesilateBase |
CAS No | 81525-10-2 |
Molecular formula | C19H17N5O2 |
Molecular weight | 347.37100 |
Structural formula |
Characteristics | off-white crystalline powder | Moisture Content | 0.25% |
Assay | 98 % |
Impurity
|
<0.3% |
Package: |
5kg/drum, 25kg/drum |
Application: |
Organic intermediates |
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View